Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].

Literature DB >> 25118844

[Statement of the German Ophthalmological Society, the Retina Society and the Professional Association of German Ophthalmologists for intravitreal treatment of macular edema in uveitis: Date: 02/07/2014].

A Heiligenhaus¹, B Bertram, C Heinz, L Krause, U Pleyer, J Roider, S Sauer, S Thurau.

Abstract

Entities: Disease

Mesh：

Substances：

Year: 2014 PMID： 25118844 DOI： 10.1007/s00347-014-3130-0

Source DB: PubMed Journal: Ophthalmologe ISSN： 0941-293X Impact factor: 1.059

× No keyword cloud information.

73 in total

1. Randomized controlled study of an intravitreous dexamethasone drug delivery system in patients with persistent macular edema.

Authors: Baruch D Kuppermann; Mark S Blumenkranz; Julia A Haller; George A Williams; David V Weinberg; Connie Chou; Scott M Whitcup
Journal: Arch Ophthalmol Date: 2007-03

2. Short-term results of a single intravitreal bevacizumab (avastin) injection versus a single intravitreal triamcinolone acetonide (kenacort) injection for the management of refractory noninfectious uveitic cystoid macular edema.

Authors: Andrés F Lasave; David G Zeballos; Wael M El-Haig; Manuel Díaz-Llopis; David Salom; J Fernando Arevalo
Journal: Ocul Immunol Inflamm Date: 2009 Nov-Dec Impact factor: 3.070

Review 3. The use of interferon alpha in Behçet disease: review of the literature.

Authors: Ina Kötter; Ilhan Günaydin; Manfred Zierhut; Nicole Stübiger
Journal: Semin Arthritis Rheum Date: 2004-04 Impact factor: 5.532

4. Longterm visual prognosis of patients with ocular Adamantiades-Behçet's disease treated with interferon-alpha-2a.

Authors: Lothar Krause; Andreas Altenburg; Uwe Pleyer; Anne-Katrin Köhler; Christos C Zouboulis; Michael H Foerster
Journal: J Rheumatol Date: 2008-04-15 Impact factor: 4.666

5. Intravitreal and orbital floor triamcinolone acetonide injections in noninfectious uveitis: a comparative study.

Authors: Martin Roesel; Matthias Gutfleisch; Carsten Heinz; Britta Heimes; Beatrix Zurek-Imhoff; Arnd Heiligenhaus
Journal: Ophthalmic Res Date: 2009-05-27 Impact factor: 2.892

6. Intravitreal bevacizumab for treatment of uveitic macular edema.

Authors: Miguel Cordero Coma; Lucia Sobrin; Sumru Onal; William Christen; C Stephen Foster
Journal: Ophthalmology Date: 2007-03-23 Impact factor: 12.079

7. Intravitreal triamcinolone acetonide as adjunctive treatment with systemic therapy for uveitic macular edema.

Authors: Zohar Habot-Wilner; Ahmed Sallam; Patricio A Pacheco; Helen H Do; Peter McCluskey; Sue Lightman
Journal: Eur J Ophthalmol Date: 2011 Impact factor: 2.597

8. Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study.

Authors: Friederike Mackensen; Carsten Heinz; Matthias D Becker; Arnd Heiligenhaus
Journal: Retina Date: 2008-01 Impact factor: 4.256

9. Dexamethasone intravitreal implant for treatment of uveitic persistent cystoid macular edema in vitrectomized patients.

Authors: Alfredo Adán; Laura Pelegrín; Amanda Rey; Victor Llorenç; Marina Mesquida; Blanca Molins; José Ríos; Johannes Keller
Journal: Retina Date: 2013 Jul-Aug Impact factor: 4.256